Search

everythinglearnresearchcommunity

for

Search:↓

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Androgens may block hair growth signals, targeting this could treat hair loss.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Acne is an important sign of androgen excess disorders in women.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Possible link between androgens and COVID-19 severity; more research needed.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Acne is caused by increased sebum, abnormal skin shedding, bacteria, and inflammation, not dirt; treatments vary from creams to antibiotics or isotretinoin, with severe cases needing a dermatologist's care.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.